Medpace Holdings, Inc. (NASDAQ: MEDP) Stock Competitors & Peer Comparison
See MEDP's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MEDP and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MEDP | $619.68 | +0.13% | 17.2B | 36.10 | $17.06 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.63% |
| TMO | $677.05 | +0.30% | 250.9B | 29.30 | $23.16 | +0.27% |
| DHR | $225.39 | +0.40% | 159.9B | 28.50 | $7.98 | +0.63% |
| NTRA | $412.24 | -0.08% | 59B | -311.95 | -$1.32 | N/A |
| A | $175.24 | +1.42% | 49.5B | 30.15 | $5.81 | +0.58% |
| IQV | $269.64 | -0.27% | 44.6B | 22.32 | $12.13 | N/A |
| WAT | $441.39 | +1.81% | 43.5B | 32.38 | $13.68 | N/A |
| IDXX | $533.53 | +2.75% | 41.7B | 37.21 | $14.22 | N/A |
| ILMN | $271.49 | +0.55% | 41.1B | 54.06 | $5.03 | N/A |
Stock Comparison
Danaher Corporation (NYSE: DHR-PB)
MEDP vs DHR-PB Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, MEDP's ROE is +1.10%, compared to DHR-PB's ROE of +0.08%. Regarding short-term risk, MEDP is more volatile compared to DHR-PB. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check DHR-PB's competition here
Thermo Fisher Scientific Inc. (NYSE: TMO)
MEDP vs TMO Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, TMO has a market cap of 250.9B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while TMO trades at $677.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas TMO's P/E ratio is 29.30. In terms of profitability, MEDP's ROE is +1.10%, compared to TMO's ROE of +0.13%. Regarding short-term risk, MEDP is more volatile compared to TMO. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check TMO's competition here
Danaher Corporation (NYSE: DHR)
MEDP vs DHR Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, DHR has a market cap of 159.9B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while DHR trades at $225.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas DHR's P/E ratio is 28.50. In terms of profitability, MEDP's ROE is +1.10%, compared to DHR's ROE of +0.08%. Regarding short-term risk, MEDP is more volatile compared to DHR. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check DHR's competition here
Natera, Inc. (NASDAQ: NTRA)
MEDP vs NTRA Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, NTRA has a market cap of 59B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while NTRA trades at $412.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas NTRA's P/E ratio is -311.95. In terms of profitability, MEDP's ROE is +1.10%, compared to NTRA's ROE of -0.12%. Regarding short-term risk, MEDP is less volatile compared to NTRA. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check NTRA's competition here
Agilent Technologies, Inc. (NYSE: A)
MEDP vs A Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, A has a market cap of 49.5B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while A trades at $175.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas A's P/E ratio is 30.15. In terms of profitability, MEDP's ROE is +1.10%, compared to A's ROE of +0.20%. Regarding short-term risk, MEDP is less volatile compared to A. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check A's competition here
IQVIA Holdings Inc. (NYSE: IQV)
MEDP vs IQV Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, IQV has a market cap of 44.6B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while IQV trades at $269.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas IQV's P/E ratio is 22.32. In terms of profitability, MEDP's ROE is +1.10%, compared to IQV's ROE of +0.22%. Regarding short-term risk, MEDP is less volatile compared to IQV. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check IQV's competition here
Waters Corporation (NYSE: WAT)
MEDP vs WAT Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, WAT has a market cap of 43.5B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while WAT trades at $441.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas WAT's P/E ratio is 32.38. In terms of profitability, MEDP's ROE is +1.10%, compared to WAT's ROE of +0.02%. Regarding short-term risk, MEDP is more volatile compared to WAT. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check WAT's competition here
IDEXX Laboratories, Inc. (NASDAQ: IDXX)
MEDP vs IDXX Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, IDXX has a market cap of 41.7B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while IDXX trades at $533.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas IDXX's P/E ratio is 37.21. In terms of profitability, MEDP's ROE is +1.10%, compared to IDXX's ROE of +0.72%. Regarding short-term risk, MEDP is less volatile compared to IDXX. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check IDXX's competition here
Illumina, Inc. (NASDAQ: ILMN)
MEDP vs ILMN Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, ILMN has a market cap of 41.1B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while ILMN trades at $271.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas ILMN's P/E ratio is 54.06. In terms of profitability, MEDP's ROE is +1.10%, compared to ILMN's ROE of +0.31%. Regarding short-term risk, MEDP is less volatile compared to ILMN. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check ILMN's competition here
Mettler-Toledo International Inc. (NYSE: MTD)
MEDP vs MTD Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, MTD has a market cap of 31.2B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while MTD trades at $1,530.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas MTD's P/E ratio is 35.50. In terms of profitability, MEDP's ROE is +1.10%, compared to MTD's ROE of -12.00%. Regarding short-term risk, MEDP is less volatile compared to MTD. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check MTD's competition here
Quest Diagnostics Incorporated (NYSE: DGX)
MEDP vs DGX Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, DGX has a market cap of 26.2B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while DGX trades at $233.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas DGX's P/E ratio is 23.44. In terms of profitability, MEDP's ROE is +1.10%, compared to DGX's ROE of +0.14%. Regarding short-term risk, MEDP is less volatile compared to DGX. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check DGX's competition here
Labcorp Holdings Inc. (NYSE: LH)
MEDP vs LH Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, LH has a market cap of 25.4B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while LH trades at $308.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas LH's P/E ratio is 18.37. In terms of profitability, MEDP's ROE is +1.10%, compared to LH's ROE of +0.12%. Regarding short-term risk, MEDP is more volatile compared to LH. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check LH's competition here
Guardant Health, Inc. (NASDAQ: GH)
MEDP vs GH Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, GH has a market cap of 23.8B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while GH trades at $176.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas GH's P/E ratio is -50.81. In terms of profitability, MEDP's ROE is +1.10%, compared to GH's ROE of +2.11%. Regarding short-term risk, MEDP is less volatile compared to GH. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check GH's competition here
Exact Sciences Corporation (NASDAQ: EXAS)
MEDP vs EXAS Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas EXAS's P/E ratio is -95.37. In terms of profitability, MEDP's ROE is +1.10%, compared to EXAS's ROE of -0.09%. Regarding short-term risk, MEDP is more volatile compared to EXAS. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check EXAS's competition here
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV)
MEDP vs ILMNV Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, ILMNV has a market cap of 17B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while ILMNV trades at $107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas ILMNV's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to ILMNV's ROE of N/A. Regarding short-term risk, MEDP is more volatile compared to ILMNV. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check ILMNV's competition here
Revvity, Inc. (NYSE: RVTY)
MEDP vs RVTY Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, RVTY has a market cap of 16.8B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while RVTY trades at $151.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas RVTY's P/E ratio is 28.22. In terms of profitability, MEDP's ROE is +1.10%, compared to RVTY's ROE of +0.03%. Regarding short-term risk, MEDP is more volatile compared to RVTY. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check RVTY's competition here
PerkinElmer, Inc. (NYSE: PKI)
MEDP vs PKI Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas PKI's P/E ratio is 41.45. In terms of profitability, MEDP's ROE is +1.10%, compared to PKI's ROE of +0.03%. Regarding short-term risk, MEDP is less volatile compared to PKI. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check PKI's competition here
Charles River Laboratories International, Inc. (NYSE: CRL)
MEDP vs CRL Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, CRL has a market cap of 14.2B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while CRL trades at $294.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas CRL's P/E ratio is 29.77. In terms of profitability, MEDP's ROE is +1.10%, compared to CRL's ROE of -0.08%. Regarding short-term risk, MEDP is less volatile compared to CRL. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check CRL's competition here
ICON Public Limited Company (NASDAQ: ICLR)
MEDP vs ICLR Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, ICLR has a market cap of 13.4B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while ICLR trades at $172.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas ICLR's P/E ratio is 14.32. In terms of profitability, MEDP's ROE is +1.10%, compared to ICLR's ROE of +0.04%. Regarding short-term risk, MEDP is less volatile compared to ICLR. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check ICLR's competition here
Qiagen N.V. (NYSE: QGEN)
MEDP vs QGEN Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, QGEN has a market cap of 9.3B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while QGEN trades at $44.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas QGEN's P/E ratio is 18.60. In terms of profitability, MEDP's ROE is +1.10%, compared to QGEN's ROE of +0.12%. Regarding short-term risk, MEDP is more volatile compared to QGEN. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check QGEN's competition here
GRAIL Inc. (NASDAQ: GRAL)
MEDP vs GRAL Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, GRAL has a market cap of 5.7B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while GRAL trades at $135.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas GRAL's P/E ratio is -13.60. In terms of profitability, MEDP's ROE is +1.10%, compared to GRAL's ROE of -0.16%. Regarding short-term risk, MEDP is less volatile compared to GRAL. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check GRAL's competition here
RadNet, Inc. (NASDAQ: RDNT)
MEDP vs RDNT Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, RDNT has a market cap of 5.6B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while RDNT trades at $70.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas RDNT's P/E ratio is 156.11. In terms of profitability, MEDP's ROE is +1.10%, compared to RDNT's ROE of -0.02%. Regarding short-term risk, MEDP is less volatile compared to RDNT. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check RDNT's competition here
BillionToOne, Inc. (NASDAQ: BLLN)
MEDP vs BLLN Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, BLLN has a market cap of 5.6B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while BLLN trades at $119.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas BLLN's P/E ratio is 173.89. In terms of profitability, MEDP's ROE is +1.10%, compared to BLLN's ROE of +0.08%. Regarding short-term risk, MEDP is less volatile compared to BLLN. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check BLLN's competition here
Sotera Health Company (NASDAQ: SHC)
MEDP vs SHC Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, SHC has a market cap of 5.3B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while SHC trades at $18.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas SHC's P/E ratio is 19.22. In terms of profitability, MEDP's ROE is +1.10%, compared to SHC's ROE of +0.27%. Regarding short-term risk, MEDP is more volatile compared to SHC. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check SHC's competition here
Syneos Health, Inc. (NASDAQ: SYNH)
MEDP vs SYNH Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas SYNH's P/E ratio is 61.40. In terms of profitability, MEDP's ROE is +1.10%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, MEDP is more volatile compared to SYNH. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check SYNH's competition here
Veracyte, Inc. (NASDAQ: VCYT)
MEDP vs VCYT Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, VCYT has a market cap of 3.6B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while VCYT trades at $46.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas VCYT's P/E ratio is 22.62. In terms of profitability, MEDP's ROE is +1.10%, compared to VCYT's ROE of +0.09%. Regarding short-term risk, MEDP is less volatile compared to VCYT. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check VCYT's competition here
CareDx, Inc (NASDAQ: CDNA)
MEDP vs CDNA Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, CDNA has a market cap of 3.3B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while CDNA trades at $63.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas CDNA's P/E ratio is 76.90. In terms of profitability, MEDP's ROE is +1.10%, compared to CDNA's ROE of +0.33%. Regarding short-term risk, MEDP is less volatile compared to CDNA. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check CDNA's competition here
Olink Holding AB (publ) (NASDAQ: OLK)
MEDP vs OLK Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas OLK's P/E ratio is -96.59. In terms of profitability, MEDP's ROE is +1.10%, compared to OLK's ROE of -0.07%. Regarding short-term risk, MEDP is more volatile compared to OLK. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check OLK's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
MEDP vs WGS Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, WGS has a market cap of 2.6B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while WGS trades at $77.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas WGS's P/E ratio is 238.69. In terms of profitability, MEDP's ROE is +1.10%, compared to WGS's ROE of -0.39%. Regarding short-term risk, MEDP is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check WGS's competition here
Personalis, Inc. (NASDAQ: PSNL)
MEDP vs PSNL Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, PSNL has a market cap of 1.7B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while PSNL trades at $16.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas PSNL's P/E ratio is -14.97. In terms of profitability, MEDP's ROE is +1.10%, compared to PSNL's ROE of -0.46%. Regarding short-term risk, MEDP is less volatile compared to PSNL. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check PSNL's competition here
OPKO Health, Inc. (NASDAQ: OPK)
MEDP vs OPK Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, OPK has a market cap of 1.2B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while OPK trades at $1.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas OPK's P/E ratio is -6.04. In terms of profitability, MEDP's ROE is +1.10%, compared to OPK's ROE of -0.06%. Regarding short-term risk, MEDP is more volatile compared to OPK. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check OPK's competition here
Castle Biosciences, Inc. (NASDAQ: CSTL)
MEDP vs CSTL Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, CSTL has a market cap of 1.1B. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while CSTL trades at $34.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas CSTL's P/E ratio is -54.44. In terms of profitability, MEDP's ROE is +1.10%, compared to CSTL's ROE of -0.04%. Regarding short-term risk, MEDP is less volatile compared to CSTL. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check CSTL's competition here
Fulgent Genetics, Inc. (NASDAQ: FLGT)
MEDP vs FLGT Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, FLGT has a market cap of 635M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while FLGT trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas FLGT's P/E ratio is 2236.00. In terms of profitability, MEDP's ROE is +1.10%, compared to FLGT's ROE of -0.08%. Regarding short-term risk, MEDP is less volatile compared to FLGT. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check FLGT's competition here
GRAIL, Inc. Common Stock (NASDAQ: GRALV)
MEDP vs GRALV Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas GRALV's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to GRALV's ROE of N/A. Regarding short-term risk, MEDP is less volatile compared to GRALV. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check GRALV's competition here
NeoGenomics, Inc. (NASDAQ: NEO)
MEDP vs NEO Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, NEO has a market cap of 495.7M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while NEO trades at $18.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas NEO's P/E ratio is 148.38. In terms of profitability, MEDP's ROE is +1.10%, compared to NEO's ROE of -0.06%. Regarding short-term risk, MEDP is less volatile compared to NEO. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check NEO's competition here
Myriad Genetics, Inc. (NASDAQ: MYGN)
MEDP vs MYGN Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, MYGN has a market cap of 400.5M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while MYGN trades at $4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas MYGN's P/E ratio is -32.62. In terms of profitability, MEDP's ROE is +1.10%, compared to MYGN's ROE of -0.33%. Regarding short-term risk, MEDP is less volatile compared to MYGN. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check MYGN's competition here
Global Cord Blood Corporation (NYSE: CO)
MEDP vs CO Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas CO's P/E ratio is 5.06. In terms of profitability, MEDP's ROE is +1.10%, compared to CO's ROE of +0.11%. Regarding short-term risk, MEDP is less volatile compared to CO. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check CO's competition here
Standard BioTools Inc. (NASDAQ: FLDM)
MEDP vs FLDM Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas FLDM's P/E ratio is -4.74. In terms of profitability, MEDP's ROE is +1.10%, compared to FLDM's ROE of +0.18%. Regarding short-term risk, MEDP is less volatile compared to FLDM. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check FLDM's competition here
Biodesix, Inc. (NASDAQ: BDSX)
MEDP vs BDSX Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, BDSX has a market cap of 247.6M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while BDSX trades at $29.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas BDSX's P/E ratio is -9.60. In terms of profitability, MEDP's ROE is +1.10%, compared to BDSX's ROE of -7.88%. Regarding short-term risk, MEDP is less volatile compared to BDSX. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check BDSX's competition here
Exagen Inc. (NASDAQ: XGN)
MEDP vs XGN Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, XGN has a market cap of 204.9M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while XGN trades at $8.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas XGN's P/E ratio is -10.47. In terms of profitability, MEDP's ROE is +1.10%, compared to XGN's ROE of -1.22%. Regarding short-term risk, MEDP is less volatile compared to XGN. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check XGN's competition here
Freenome, Inc. (NASDAQ: FRNM)
MEDP vs FRNM Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, FRNM has a market cap of 132.1M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while FRNM trades at $15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas FRNM's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to FRNM's ROE of N/A. Regarding short-term risk, MEDP is less volatile compared to FRNM. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check FRNM's competition here
Genetron Holdings Limited (NASDAQ: GTH)
MEDP vs GTH Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas GTH's P/E ratio is -1.11. In terms of profitability, MEDP's ROE is +1.10%, compared to GTH's ROE of -1.01%. Regarding short-term risk, MEDP is more volatile compared to GTH. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check GTH's competition here
Genetic Technologies Limited (NASDAQ: GENE)
MEDP vs GENE Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas GENE's P/E ratio is -38.25. In terms of profitability, MEDP's ROE is +1.10%, compared to GENE's ROE of -1.85%. Regarding short-term risk, MEDP is more volatile compared to GENE. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check GENE's competition here
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX)
MEDP vs IMDX Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, IMDX has a market cap of 102.7M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while IMDX trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas IMDX's P/E ratio is -2.13. In terms of profitability, MEDP's ROE is +1.10%, compared to IMDX's ROE of +2.72%. Regarding short-term risk, MEDP is less volatile compared to IMDX. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check IMDX's competition here
Sera Prognostics, Inc. (NASDAQ: SERA)
MEDP vs SERA Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, SERA has a market cap of 77.1M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while SERA trades at $2.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas SERA's P/E ratio is -3.11. In terms of profitability, MEDP's ROE is +1.10%, compared to SERA's ROE of -0.47%. Regarding short-term risk, MEDP is less volatile compared to SERA. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check SERA's competition here
Precipio, Inc. (NASDAQ: PRPO)
MEDP vs PRPO Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, PRPO has a market cap of 43M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while PRPO trades at $23.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas PRPO's P/E ratio is -37.09. In terms of profitability, MEDP's ROE is +1.10%, compared to PRPO's ROE of -0.08%. Regarding short-term risk, MEDP is less volatile compared to PRPO. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check PRPO's competition here
Quantum Cyber N.V. (NASDAQ: QUCY)
MEDP vs QUCY Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, QUCY has a market cap of 31.2M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while QUCY trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas QUCY's P/E ratio is -0.06. In terms of profitability, MEDP's ROE is +1.10%, compared to QUCY's ROE of -3.65%. Regarding short-term risk, MEDP is less volatile compared to QUCY. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check QUCY's competition here
MDxHealth S.A. (NASDAQ: MDXH)
MEDP vs MDXH Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, MDXH has a market cap of 28.1M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while MDXH trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas MDXH's P/E ratio is -0.75. In terms of profitability, MEDP's ROE is +1.10%, compared to MDXH's ROE of +1.43%. Regarding short-term risk, MEDP is less volatile compared to MDXH. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check MDXH's competition here
Akumin Inc. (NASDAQ: AKU)
MEDP vs AKU Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas AKU's P/E ratio is -0.13. In terms of profitability, MEDP's ROE is +1.10%, compared to AKU's ROE of -5.32%. Regarding short-term risk, MEDP is less volatile compared to AKU. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check AKU's competition here
Burning Rock Biotech Limited (NASDAQ: BNR)
MEDP vs BNR Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, BNR has a market cap of 18.6M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while BNR trades at $18.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas BNR's P/E ratio is -20.26. In terms of profitability, MEDP's ROE is +1.10%, compared to BNR's ROE of -0.13%. Regarding short-term risk, MEDP is less volatile compared to BNR. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check BNR's competition here
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
MEDP vs CEMI Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas CEMI's P/E ratio is -0.63. In terms of profitability, MEDP's ROE is +1.10%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, MEDP is more volatile compared to CEMI. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check CEMI's competition here
Enzo Biochem, Inc. (NYSE: ENZ)
MEDP vs ENZ Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas ENZ's P/E ratio is -2.24. In terms of profitability, MEDP's ROE is +1.10%, compared to ENZ's ROE of -0.39%. Regarding short-term risk, MEDP is less volatile compared to ENZ. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check ENZ's competition here
Psychemedics Corporation (NASDAQ: PMD)
MEDP vs PMD Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas PMD's P/E ratio is -5.24. In terms of profitability, MEDP's ROE is +1.10%, compared to PMD's ROE of -0.32%. Regarding short-term risk, MEDP is more volatile compared to PMD. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check PMD's competition here
23andMe Holding Co. (NASDAQ: ME)
MEDP vs ME Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas ME's P/E ratio is -0.03. In terms of profitability, MEDP's ROE is +1.10%, compared to ME's ROE of -42.03%. Regarding short-term risk, MEDP is more volatile compared to ME. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check ME's competition here
Mainz Biomed B.V. (NASDAQ: MYNZ)
MEDP vs MYNZ Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas MYNZ's P/E ratio is -0.68. In terms of profitability, MEDP's ROE is +1.10%, compared to MYNZ's ROE of -1.80%. Regarding short-term risk, MEDP is less volatile compared to MYNZ. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check MYNZ's competition here
Check-Cap Ltd. (NASDAQ: CHEK)
MEDP vs CHEK Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas CHEK's P/E ratio is -0.43. In terms of profitability, MEDP's ROE is +1.10%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, MEDP is less volatile compared to CHEK. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check CHEK's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
MEDP vs BIAFW Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, BIAFW has a market cap of 9.8M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while BIAFW trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas BIAFW's P/E ratio is 1.04. In terms of profitability, MEDP's ROE is +1.10%, compared to BIAFW's ROE of -2.57%. Regarding short-term risk, MEDP is less volatile compared to BIAFW. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check BIAFW's competition here
Centogene N.V. (NASDAQ: CNTG)
MEDP vs CNTG Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas CNTG's P/E ratio is -0.23. In terms of profitability, MEDP's ROE is +1.10%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, MEDP is more volatile compared to CNTG. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check CNTG's competition here
Advanced Biomed Inc. Common Stock (NASDAQ: ADVB)
MEDP vs ADVB Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, ADVB has a market cap of 9.3M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while ADVB trades at $6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas ADVB's P/E ratio is -61.18. In terms of profitability, MEDP's ROE is +1.10%, compared to ADVB's ROE of -0.21%. Regarding short-term risk, MEDP is less volatile compared to ADVB. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check ADVB's competition here
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
MEDP vs NDRA Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, NDRA has a market cap of 7.5M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while NDRA trades at $6.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas NDRA's P/E ratio is -0.88. In terms of profitability, MEDP's ROE is +1.10%, compared to NDRA's ROE of -2.25%. Regarding short-term risk, MEDP is less volatile compared to NDRA. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check NDRA's competition here
Applied DNA Sciences, Inc. (NASDAQ: APDN)
MEDP vs APDN Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas APDN's P/E ratio is -0.10. In terms of profitability, MEDP's ROE is +1.10%, compared to APDN's ROE of -7.23%. Regarding short-term risk, MEDP is less volatile compared to APDN. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check APDN's competition here
Invitae Corporation (NYSE: NVTA)
MEDP vs NVTA Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas NVTA's P/E ratio is -0.00. In terms of profitability, MEDP's ROE is +1.10%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, MEDP is less volatile compared to NVTA. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check NVTA's competition here
LumiraDx Limited (NASDAQ: LMDXW)
MEDP vs LMDXW Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, MEDP's ROE is +1.10%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, MEDP is less volatile compared to LMDXW. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check LMDXW's competition here
LumiraDx Limited (NASDAQ: LMDX)
MEDP vs LMDX Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas LMDX's P/E ratio is -0.01. In terms of profitability, MEDP's ROE is +1.10%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, MEDP is less volatile compared to LMDX. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check LMDX's competition here
DermTech, Inc. (NASDAQ: DMTK)
MEDP vs DMTK Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas DMTK's P/E ratio is -0.04. In terms of profitability, MEDP's ROE is +1.10%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, MEDP is less volatile compared to DMTK. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check DMTK's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAF)
MEDP vs BIAF Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, BIAF has a market cap of 3.1M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while BIAF trades at $6.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas BIAF's P/E ratio is -0.87. In terms of profitability, MEDP's ROE is +1.10%, compared to BIAF's ROE of -2.57%. Regarding short-term risk, MEDP is less volatile compared to BIAF. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check BIAF's competition here
Inotiv, Inc. (NASDAQ: NOTV)
MEDP vs NOTV Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, NOTV has a market cap of 2.8M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while NOTV trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas NOTV's P/E ratio is -0.03. In terms of profitability, MEDP's ROE is +1.10%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, MEDP is less volatile compared to NOTV. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check NOTV's competition here
SeqLL Inc. (NASDAQ: SQL)
MEDP vs SQL Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas SQL's P/E ratio is -0.40. In terms of profitability, MEDP's ROE is +1.10%, compared to SQL's ROE of -30.46%. Regarding short-term risk, MEDP is less volatile compared to SQL. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check SQL's competition here
Aspira Women's Health Inc. (NASDAQ: AWH)
MEDP vs AWH Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas AWH's P/E ratio is -0.09. In terms of profitability, MEDP's ROE is +1.10%, compared to AWH's ROE of +1.62%. Regarding short-term risk, MEDP is more volatile compared to AWH. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check AWH's competition here
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM)
MEDP vs HTGM Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas HTGM's P/E ratio is -0.03. In terms of profitability, MEDP's ROE is +1.10%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, MEDP is more volatile compared to HTGM. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check HTGM's competition here
Biocept, Inc. (NASDAQ: BIOC)
MEDP vs BIOC Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas BIOC's P/E ratio is -0.01. In terms of profitability, MEDP's ROE is +1.10%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, MEDP is less volatile compared to BIOC. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check BIOC's competition here
SeqLL Inc. (NASDAQ: SQLLW)
MEDP vs SQLLW Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, SQLLW has a market cap of 179.6K. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas SQLLW's P/E ratio is -0.00. In terms of profitability, MEDP's ROE is +1.10%, compared to SQLLW's ROE of -30.46%. Regarding short-term risk, MEDP is less volatile compared to SQLLW. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check SQLLW's competition here
iSpecimen Inc. (NASDAQ: ISPC)
MEDP vs ISPC Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, ISPC has a market cap of 165.2K. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while ISPC trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas ISPC's P/E ratio is -0.04. In terms of profitability, MEDP's ROE is +1.10%, compared to ISPC's ROE of -5.24%. Regarding short-term risk, MEDP is less volatile compared to ISPC. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check ISPC's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
MEDP vs WGSWW Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, MEDP's ROE is +1.10%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, MEDP is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check WGSWW's competition here
ENDRA Life Sciences Inc. Warrants (NASDAQ: NDRAW)
MEDP vs NDRAW Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas NDRAW's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to NDRAW's ROE of -2.25%. Regarding short-term risk, MEDP is less volatile compared to NDRAW. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check NDRAW's competition here
PAREXEL Intl Corp. (NASDAQ: PRXL)
MEDP vs PRXL Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, PRXL has a market cap of 0. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas PRXL's P/E ratio is 42.97. In terms of profitability, MEDP's ROE is +1.10%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, MEDP is more volatile compared to PRXL. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check PRXL's competition here
BioNano Genomics, Inc. WT EXP 082123 (NASDAQ: BNGOW)
MEDP vs BNGOW Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas BNGOW's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to BNGOW's ROE of -0.79%. Regarding short-term risk, MEDP is less volatile compared to BNGOW. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check BNGOW's competition here
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
MEDP vs OCDX Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, OCDX has a market cap of 0. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas OCDX's P/E ratio is -42.28. In terms of profitability, MEDP's ROE is +1.10%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, MEDP is less volatile compared to OCDX. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check OCDX's competition here
23andMe Holding Co. (NASDAQ: MEUSW)
MEDP vs MEUSW Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas MEUSW's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to MEUSW's ROE of -42.03%. Regarding short-term risk, MEDP is less volatile compared to MEUSW. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check MEUSW's competition here
Danaher Corporation (NYSE: DHR-PA)
MEDP vs DHR-PA Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, MEDP's ROE is +1.10%, compared to DHR-PA's ROE of +0.08%. Regarding short-term risk, MEDP is less volatile compared to DHR-PA. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check DHR-PA's competition here
Check-Cap Ltd (NASDAQ: CHEKZ)
MEDP vs CHEKZ Comparison September 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 17.2B. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, MEDP is priced at $619.68 on the NASDAQ, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.10, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, MEDP is less volatile compared to CHEKZ. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check CHEKZ's competition here